Dianthus Therapeutics (DNTH) Prepaid Assets (2017 - 2025)
Dianthus Therapeutics' (DNTH) quarterly Prepaid Assets came in at $698000.0 in Q4 2025, little changed year-on-year from $696000.0 in Q4 2024, and down 10.28% quarter-over-quarter from $778000.0 in Q3 2025.
Dianthus Therapeutics (DNTH) Prepaid Assets (2017 - 2025) Analysis & Trends
Dianthus Therapeutics' Prepaid Assets history runs 9 years deep, the most recent figure standing at $698000.0 for Q4 2025.
- On a quarterly basis, Prepaid Assets changed 0.29% year-over-year to $698000.0 in Q4 2025; TTM through Dec 2025 was $698000.0, a 0.29% change from a year earlier, with the FY2025 full-year figure at $698000.0, changed 0.29% from the prior year.
- Prepaid Assets slipped to $698000.0 in Q4 2025 per DNTH's latest filing, from $778000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $3.9 million in Q3 2021 and bottomed at $32000.0 in Q4 2022.
- The 5-year median for Prepaid Assets is $938500.0 (2023), against an average of $1.7 million.
- Across the five-year window, Prepaid Assets tumbled 99.15% in 2022 and surged 1762.5% in 2023, its largest moves.
- Year by year, Prepaid Assets stood at $3.8 million in 2021, then tumbled by 99.15% to $32000.0 in 2022, then jumped by 1762.5% to $596000.0 in 2023, then gained by 16.78% to $696000.0 in 2024, then advanced by 0.29% to $698000.0 in 2025.
- Per Business Quant, the three latest DNTH Prepaid Assets figures stand at $698000.0 (Q4 2025), $778000.0 (Q3 2025), and $266000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Dianthus Therapeutics | 3.92 Bn | 3.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 698,000.00 |
| Sep 30, 2025 | 778,000.00 |
| Jun 30, 2025 | 266,000.00 |
| Mar 31, 2025 | 392,000.00 |
| Dec 31, 2024 | 696,000.00 |
| Sep 30, 2024 | 50,000.00 |
| Jun 30, 2024 | 203,000.00 |
| Mar 31, 2024 | 3.01 Mn |
| Dec 31, 2023 | 596,000.00 |
| Sep 30, 2023 | 832,000.00 |
| Jun 30, 2023 | 1.05 Mn |
| Mar 31, 2023 | 2.91 Mn |
| Dec 31, 2022 | 32,000.00 |
| Sep 30, 2022 | 3.81 Mn |
| Jun 30, 2022 | 2.62 Mn |
| Mar 31, 2022 | 3.64 Mn |
| Dec 31, 2021 | 3.77 Mn |
| Sep 30, 2021 | 3.86 Mn |
| Jun 30, 2021 | 2.38 Mn |
| Mar 31, 2021 | 2.81 Mn |